Denmark: New research has revealed that among patients with chronic obstructive pulmonary disease and atrial arrhythmias such ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with ...

Chronic obstructive pulmonary disease, or COPD, is the 5th-leading cause of death in the United States and the cause of more ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...

Editor: COPD (Chronic Obstructive Pulmonary Disease) it is the third leading cause of death worldwide and the leading cause of disability. Early diagnosis is crucial. COPD affects an estimated 30 ...

Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...

Asthma and COPD patients in the UK are set to receive faster, community-based care under a £10 million NHS initiative, ...

Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...